Resident Rounds: Part 1 - Program Spotlight: The University of Colorado Denver Dermatology Residency Program

August 2015 | Volume 14 | Issue 8 | Features | 909 | Copyright © August 2015

David A. Norris MD, Ramin Fathi MD

University of Colorado, Department of Dermatology, Denver, CO

Resident Rounds is a section of the JDD dedicated to highlighting various dermatology departments with residency training programs. Resident Rounds includes 3 sections: (1) a program spotlight highlighting pertinent information about the department and residency training program; (2) a section presenting study materials used by residents at the program; and (3) a section designed to highlight recent interesting cases seen at the institution. This issue of Resident Rounds features the Department of Dermatology at University of Colorado. The editor of Resident Rounds is Dr. Ali Alikhan. If you are interested in highlighting your training program in a future issue, please contact Dr. Alikhan at
Over the past decade, The Department of Dermatology at the University of Colorado School of Medicine has transformed into a powerful academic program that has achieved excellence in education, patient care, and research. The CU Health Sciences Center on the Anschutz Medical Campus (AMC) is located in Aurora, just east of Denver. There, state-of-the-art facilities for clinical care, education and research provide an integrated and collaborative environment for the professional Schools of Medicine, Public Health, Pharmacy, Dentistry, and Nursing. This campus is also home to the University of Colorado Hospital and the Children's Hospital of Colorado (formerly The Children's Hospital). A new Department of Veterans Affairs Hospital is under construction.
Our department has a comprehensive clinical program with a highly varied patient population at multiple sites. The main Dermatology Clinic at AMC handles 25,000 outpatient visits per year with a focus on general adult dermatology, cutaneous oncology and procedural dermatology/Mohs Surgery. It has full surgical facilities and phototherapy suites and shares space with the comprehensive Melanoma Clinic. The Dermatology Clinic at the Children's Hospital of Colorado serves 12,000 patients per year, specializing in complex pediatric dermatology cases, vascular birthmarks and epidermolysis bullosa. Dermatology in the Denver VA hospital is a comprehensive clinical service treating 9,000 patients per year with special attention to skin cancer and teledermatology. A highly effective Dermatology Clinic at Denver Health and Hospitals serves the needs of residents within the City and County of Denver, providing care for 8,000 patients per year. Cosmetic and Aesthetic services are provided at the freestanding CU Cosmetics Clinic. This clinic is staffed by faculty from the Departments of Dermatology and Plastic Surgery and offers a number of cosmetic services including sclerotherapy, laser therapy, chemical peels, dermabrasion, hair removal, Botox and soft tissue augmentation. Dermatology residents currently participate in a Residents Clinic at this facility during their third year. Dermatopathology services are centering in a freestanding laboratory on the AMC.
table 1
Research in the Department of Dermatology has experienced spectacular growth with important recruitments of faculty specializing in carcinogenesis, stem cell biology and regenerative medicine, immunology, and developmental biology. Dennis Roop, PhD, Director of the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, and 16 key members of this center have faculty appointments in the Department of Dermatology. Since coming to Colorado in 2007, Dr. Roop has raised 35 million dollars in research funding for his center. He has helped develop an extensive collaborative network of researchers in many departments resulting in important translational research. We have also developed a large group of scientists working in skin disease-related research, funded by a P30 grant from the NIH as the UCD Skin Diseases Research Center. Development of new cutting-edge treatments for skin disease is a primary goal of our research programs in oncology, stem cell biology and immunology. We have a well developed drug development program centered in two biotechnology companies founded by two members of the faculty, Yosef Refaeli, PhD and Xiao-Jing Wang, PhD. Robert Dellavalle, MD, PhD is an important part of our patient-oriented research efforts, serving as Director of Dermatoepidemiology. He recently hosted the worldwide Cochrane and Campbell Research Colloquium in Keystone, Colorado.